HOME ·

innovative drug

GENFLEET-B (02595.HK): Oral KRAS G12D Inhibitor Advances, 44% ORR in CRC Combo and 41% cORR in PDAC
Tags：
GENFLEET-B02595.HKinnovative drug
2026-10-15
ABBISKO-B (02256.HK): Lavengratinib shows positive interim Phase II results in achondroplasia
Tags：
ABBISKO-B02256.HKinnovative drug
2026-09-21
Grand Pharmaceutical (00512.HK): TCM Class 1.1 Innovative Drug GPN01360 Completes First Patient Enrollment in Phase III Depression Study
Tags：
GRANDPHARMA00512.HKinnovative drug
2026-07-23
Regent Pacific Group (00575.HK): Senstend™ Approved for Marketing by National Medical Products Administration
Tags：
Regent Pacific Group00575.HKinnovative drug
2026-06-16
Takeda and Protagonist Jointly Announce Rusfertide Granted FDA Priority Review,Set to Become the First-in-Class Therapy for Polycythemia Vera
Tags：
TakedaProtagonistinnovative drug
2026-03-03
Takeda's New Drug Application for Oveporexton Accepted by the FDA,Granted Priority Review Status
Tags：
Takedainnovative drug
2026-02-11
SKB BIO-B(06990.HK): TROP2 ADC Combined with Immunotherapy Gets Breakthrough Designation, Accumulating Five Relevant Qualifications
Tags：
SKB BIO-B06990.HKinnovative drug
2026-01-05